MNKD MannKind Corporation - Common Stock
$4,26
Harga · Agu 19, 2026
Fundamental per Agu 5, 2026
Rentang 52M
$2–$7
47% of range
Peringkat Analis
BUY
14 analysts
Target Harga
$8
+87% upside
P/E (TTM)
212.9
ROE
-11.1%
Margin Laba Bersih
1.7%
Tentang MannKind Corporation - Common Stock Tinjauan perusahaan dari Wikipedia
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
Baca selengkapnya
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.
History
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).
The FDA approved Afrezza on June 27, 2014.
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.
In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.
Products and product candidates
The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.
Leadership
Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.
In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.
Facilities
MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
MNKD Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$4.26
Kapitalisasi Pasar
$1.31B
P/E (TTM)
212.9
EPS (TTM)
$0.02
Pendapatan (TTM)
$349M
Imbal Hasil Dividen
—
ROE
-11.1%
D/E Utang/Ekuitas
—
Rentang 52M
$2 – $7
MNKD Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$349M
2016-12-31
→
2025-12-31
EPS
$0.02
2016-12-31
→
2025-12-31
Arus Kas Bebas
$14M
2018-12-31
→
2025-12-31
Margin
1.7%
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
MNKD
Median Rekan
P/E (TTM)
212.9
—
P/S (TTM)
3.8
10.7
P/B
-25.7
5.2
Price / FCF (Harga / FCF)
95.7
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
MNKD
Median Rekan
Operating Margin (Margin Operasi)
11.1%
—
Net Profit Margin (Margin Laba Bersih)
1.7%
-140.3%
ROA
0.99%
-44.7%
ROE
-11.1%
-51.5%
ROIC
-316.9%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
MNKD
Median Rekan
Current Ratio (Rasio Lancar)
1.7
9.5
Quick Ratio (Rasio Cepat)
1.2
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
MNKD
Median Rekan
Revenue YoY (Pendapatan YoY)
22.2%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
51.8%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
39.9%
—
EPS YoY
-80.0%
—
Net Income YoY (Laba Bersih YoY)
-78.8%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
MNKD
Median Rekan
MNKD Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
14 analis
- Beli Kuat 4 28,6%
- Beli 8 57,1%
- Tahan 2 14,3%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
8 analis · 2026-08-17
Median
$7.50
← Di bawah semua target
$4.26
Rendah
$4.75
Tinggi
$13.00
Target median
$7.50
+76,2%
Target rata-rata
$7.97
+87,2%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.03%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.06 | $-0.00 | -0.06% |
| 31 Maret 2026 | $-0.05 | $-0.00 | -0.05% |
| 31 Des. 2025 | $-0.05 | $0.01 | -0.06% |
| 30 Sep. 2025 | $0.07 | $0.02 | 0.05% |
| 30 Juni 2025 | $0.00 | $0.05 | -0.05% |
| 31 Maret 2025 | $0.04 | $0.04 | -0.00% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Cost of Revenue | $27M | $17M | $21M | $16M | $17M | $15M | $20M | $19M | $17M | $17M | $65M | · | |
| SG&A Expense | $144M | $94M | $94M | $91M | $32M | $25M | $75M | $80M | $75M | $47M | $41M | $79M | |
| Operating Expenses | $88M | $77M | $63M | $57M | $39M | $25M | $108M | $104M | $120M | $107M | $345M | $180M | |
| Operating Income | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-108M | $67M | $-345M | $-180M | |
| Interest Expense | · | · | $15M | $15M | $15M | · | · | · | · | · | $24M | $20M | |
| Interest Income | $8M | $13M | $6M | $3M | $112.0K | $167.0K | $997.0K | $501.0K | $293.0K | $85.0K | $18.0K | $9.0K | |
| Other Non-op | $-1M | $32.0K | $122.0K | $-102.0K | $-239.0K | $23.0K | $-926.0K | $-437.0K | $13.0K | $-597.0K | $1M | $2M | |
| Pretax Income | $1M | $31M | $-10M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Income Tax | $-4M | $3M | $2M | $0 | $0 | $-218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| EPS (Basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | |
| EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | |
| Shares (Basic) | 305,639,000 | 274,415,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,053,000 | 81,233,000 | 77,045,000 | |
| Shares (Diluted) | 314,112,000 | 283,844,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,085,000 | 81,233,000 | 77,045,000 | |
| EBITDA | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-106M | · | $-334M | $-170M |
Neraca 28
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $46M | $238M | $70M | $124M | $67M | $30M | $71M | $44M | $23M | $59M | $121M | |
| Short-term Investments | $96M | $151M | $57M | $101M | $80M | $0 | $20M | · | · | · | · | · | |
| Receivables | $38M | $12M | $15M | $17M | $5M | $4M | $4M | $4M | $3M | $302.0K | $23.0K | $50M | |
| Inventory | $35M | $28M | $29M | $22M | $7M | $5M | $4M | $4M | $3M | $2M | · | $10M | |
| Prepaid Expense | $47M | $31M | $35M | $25M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $20M | |
| Current Assets | $292M | $268M | $373M | $235M | $219M | $79M | $61M | $82M | $57M | $77M | $77M | $201M | |
| PP&E (Net) | $82M | $85M | $84M | $45M | $37M | $26M | $27M | $26M | $27M | $29M | $49M | $192M | |
| PP&E (Gross) | $196M | $192M | $186M | $144M | $134M | $123M | $122M | $126M | $128M | $129M | $168M | $310M | |
| Accum. Depreciation | $114M | $107M | $102M | $99M | $98M | $97M | $95M | $100M | $101M | $100M | $120M | $118M | |
| Goodwill | $68M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $27M | $7M | $10M | $8M | $3M | $6M | $249.0K | $437.0K | $648.0K | $1M | $848.0K | |
| Total Assets | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Accounts Payable | $9M | $7M | $10M | $11M | $7M | $6M | $5M | $5M | $7M | $3M | $16M | $7M | |
| Accrued Liabilities | $65M | $40M | $42M | $36M | $27M | $20M | $16M | $15M | $12M | $8M | $8M | $26M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Current Liabilities | $171M | $82M | $104M | $67M | $48M | $74M | $66M | $75M | $88M | $92M | $268M | $403M | |
| Capital Leases | $11M | $12M | $4M | $5M | $1M | $1M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $5M | · | · | · | · | · | $15M | $12M | |
| Total Liabilities | $843M | $473M | $721M | $546M | $531M | $289M | $284M | $283M | $299M | $291M | $477M | $468M | |
| Long-term Debt | $355M | $36M | $269M | $273M | $281M | $122M | $119M | $102M | $157M | · | · | · | |
| Total Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $4M | $4M | |
| Retained Earnings | $-3.20B | $-3.20B | $-3.23B | $-3.22B | $-3.13B | $-3.05B | $-2.99B | $-2.94B | $-2.85B | $-2.74B | $-2.86B | $-2.49B | |
| AOCI | $115.0K | $1M | · | · | · | · | $-19.0K | $-19.0K | $-18.0K | $-24.0K | $-20.0K | $-14.0K | |
| Stockholders' Equity | $-51M | $-79M | $-246M | $-251M | $-209M | $-180M | $-191M | $-175M | $-215M | $-184M | $-350M | $-74M | |
| Liabilities + Equity | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Shares Outstanding | 307,832,587 | 302,959,782 | 270,034,495 | 263,793,305 | 251,477,562 | 242,117,089 | 211,787,573 | 187,029,967 | 119,053,414 | 95,680,831 | 85,734,188 | 406,059,089 |
Arus Kas 18
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $7M | $5M | $3M | $2M | $2M | $972.0K | $3M | $2M | $2M | $11M | $10M | |
| Stock-based Comp | $24M | $21M | $18M | $13M | $12M | $7M | $6M | $7M | $5M | $5M | $9M | $49M | |
| Deferred Tax | $-19M | $4M | $7M | $-10M | $-20M | $-5M | $-5M | $-11M | $-260M | $48M | $-80M | $-66M | |
| Amort. of Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $6M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | $306M | · | $291M | $144M | |
| Operating Cash Flow | $18M | $43M | $34M | $-81M | $-62M | $-28M | $-88M | $-38M | $-65M | $-78M | $-57M | $4M | |
| CapEx | $5M | $10M | $42M | $8M | $11M | $801.0K | $3M | $354.0K | · | $1M | $10M | $24M | |
| Investing Cash Flow | $-305M | $-97M | $-2M | $5M | $-152M | $15M | $-23M | $-234.0K | $17M | $-1M | · | · | |
| Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $564.0K | $893.0K | $28M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $564.0K | · | $28M | · | |
| Financing Cash Flow | $315M | $-137M | $137M | $21M | $270M | $50M | $70M | $61M | $74M | $43M | · | · | |
| Net Change in Cash | $29M | $-191M | $169M | $-54M | $57M | $37M | $-41M | $23M | $25M | $-36M | $-62M | $50M | |
| Taxes Paid | $2M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M | $-29M | $-91M | $-38M | · | · | $-68M | $-20M | |
| Levered FCF | · | · | $-26M | $-98M | · | · | · | · | · | · | $-92M | · |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | · | · | · | |
| Net Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | · | · | · | |
| Pretax Margin | 0.40% | 10.7% | -5.2% | -87.6% | -107.3% | -88.2% | -82.3% | -311.3% | -998.6% | · | · | · | |
| EBITDA Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -905.8% | · | · | · | |
| ROA | 0.99% | 6.3% | -3.1% | -28.4% | -37.7% | -56.6% | -51.5% | -90.5% | -122.4% | · | -141.5% | -60.8% | |
| ROE | -11.1% | -19.1% | 4.8% | 35.8% | 41.1% | 31.2% | 27.7% | 45.7% | 58.9% | · | 173.8% | 379.7% | |
| ROIC | -316.9% | -83.2% | -4.1% | 25.6% | 22.5% | 26.5% | 24.0% | 43.9% | 50.4% | · | 98.4% | · |
Likuiditas & Solvabilitas 4
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 | 1.1 | 0.9 | 1.1 | 0.7 | · | 0.3 | 0.5 | |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 | 1.0 | 0.8 | 1.0 | 0.5 | · | 0.2 | 0.4 | |
| Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | 0.6 | -6.7 | · | · | · | · | · | · | -14.3 | -8.8 |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.1 | · | 0.0 | · | |
| Inventory Turnover | 0.8 | 0.6 | 0.8 | 1.1 | 2.8 | 3.3 | 5.2 | 6.2 | 6.9 | · | · | · | |
| Receivables Turnover | 13.9 | 21.4 | 12.6 | 9.3 | 16.4 | 16.9 | 16.7 | 8.2 | 7.6 | · | 0.0 | · |
Tingkat Pertumbuhan 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.2% | 43.5% | 99.4% | 32.2% | 15.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 51.8% | 55.8% | 45.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -80.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -78.8% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 13
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Net Income TTM | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Market Cap | $1.75B | $1.95B | $983M | $1.39B | $1.10B | $758M | $273M | $198M | $276M | · | $3.11B | $10.60B | |
| Enterprise Value | · | · | · | · | · | · | $228M | · | · | · | · | · | |
| P/E | 283.5 | 64.3 | -91.0 | -15.5 | -13.7 | -12.0 | -2.0 | -1.8 | -2.1 | 2.4 | -1.6 | -10.2 | |
| P/S | 5.0 | 6.8 | 4.9 | 13.9 | 14.6 | 11.6 | 4.3 | 7.1 | 23.5 | · | · | · | |
| P/B | -34.2 | -24.7 | -4.0 | -5.5 | -5.2 | -4.2 | -1.4 | -1.1 | -1.3 | · | -8.9 | -143.7 | |
| P / Cash Flow | 95.6 | 45.8 | 28.8 | -17.2 | -17.8 | -26.9 | -3.1 | -5.3 | -4.3 | · | -54.3 | 2593.8 | |
| P / FCF | 127.5 | 59.4 | -117.8 | -15.7 | -15.0 | -26.2 | -3.0 | -5.2 | · | · | -46.0 | -529.6 | |
| EV / EBITDA | · | · | · | · | · | · | -5.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | -2.5 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 3.6 | · | · | · | · | · | |
| Earnings Yield | 0.35% | 1.6% | -1.1% | -6.5% | -7.3% | -8.3% | -48.8% | -56.6% | -48.7% | 42.5% | -62.6% | -9.8% |
Laporan Laba Rugi 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109M | $90M | $112M | $82M | $77M | $78M | $77M | $70M | $72M | $66M | $58M | $51M | $49M | $41M | $36M | $33M | |
| Cost of Revenue | $14M | $8M | $14M | $4M | $5M | $4M | $5M | $3M | $6M | $4M | $6M | $4M | $5M | $6M | $4M | $5M | |
| SG&A Expense | $58M | $54M | $58M | $29M | $32M | $25M | $24M | $24M | $24M | $22M | $61M | $11M | $12M | $11M | $64M | $9M | |
| Operating Expenses | $30M | $92M | $-103M | $63M | $21M | $56M | $-86M | $57M | $56M | $50M | $18M | $14M | $14M | $16M | $16M | $17M | |
| Operating Income | $-350.0K | $-2M | $-8M | $19M | $5M | $22M | $26M | $13M | $17M | $17M | $8M | $5M | $2M | $-6M | $-13M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6M | $3M | · | $3M | $7M | $3M | · | $3M | |
| Interest Income | $1M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $663.0K | |
| Other Non-op | $-5M | $-3M | $23M | $-11M | $-4M | $-9M | $24M | $110.0K | $-18M | $-6M | $-164.0K | $318.0K | $-143.0K | $111.0K | $105.0K | $-207.0K | |
| Pretax Income | $-19M | $-16M | $-21M | $8M | $940.0K | $14M | $8M | $13M | $-2M | $11M | $3M | $2M | $-5M | $-10M | $-18M | $-14M | |
| Income Tax | $-106.0K | $253.0K | $-5M | $-204.0K | $272.0K | $459.0K | $1M | $1M | $323.0K | $264.0K | $2M | $0 | $0 | $0 | · | $0 | |
| Net Income | $-19M | $-17M | $-16M | $8M | $668.0K | $13M | $7M | $12M | $-2M | $11M | $1M | $2M | $-5M | $-10M | $-18M | $-14M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| Shares (Basic) | 309,191,000 | 308,267,000 | -609,602,000 | 306,806,000 | 304,954,000 | 303,481,000 | -543,995,000 | 274,998,000 | 273,056,000 | 270,356,000 | -531,313,000 | 268,732,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| Shares (Diluted) | 309,191,000 | 308,267,000 | -629,907,000 | 311,638,000 | 311,484,000 | 320,897,000 | -598,638,000 | 284,693,000 | 273,056,000 | 324,733,000 | -586,351,000 | 323,770,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| EBITDA | · | $-2M | · | $19M | $5M | $22M | · | $13M | $17M | $17M | · | $5M | $2M | $-6M | · | $-10M |
Neraca 25
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M | $193M | · | $83M | $86M | $86M | · | $54M | |
| Short-term Investments | $58M | $81M | $96M | $133M | $122M | $134M | $151M | $189M | $151M | $107M | · | $58M | $58M | $80M | · | $111M | |
| Receivables | $43M | $28M | $38M | $17M | $27M | $29M | $12M | $18M | $23M | $20M | · | $22M | $28M | $20M | · | $23M | |
| Inventory | $44M | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M | $26M | · | $27M | $25M | $22M | · | $18M | |
| Prepaid Expense | $47M | $40M | $47M | $54M | $44M | $34M | $31M | $31M | $30M | $36M | · | $36M | $33M | $15M | · | $12M | |
| Current Assets | $246M | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M | $383M | · | $226M | $230M | $223M | · | $218M | |
| PP&E (Net) | $85M | $83M | $82M | $83M | $83M | $84M | $85M | $85M | $85M | $84M | · | $80M | $70M | $55M | · | $41M | |
| PP&E (Gross) | $203M | $198M | $196M | $195M | $194M | $192M | $192M | $192M | $190M | $186M | · | $182M | $170M | $154M | · | $140M | |
| Accum. Depreciation | $118M | $116M | $114M | $113M | $111M | $109M | $107M | $107M | $105M | $103M | · | $101M | $100M | $100M | · | $99M | |
| Goodwill | $68M | $68M | $68M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Assets | $17M | $22M | $20M | $19M | $20M | $28M | $27M | $26M | $16M | $7M | · | $8M | $8M | $16M | · | $17M | |
| Total Assets | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Accounts Payable | $11M | $16M | $9M | $7M | $10M | $5M | $7M | $6M | $10M | $7M | · | $17M | $17M | $14M | · | $10M | |
| Accrued Liabilities | $61M | $59M | $65M | $31M | $31M | $40M | $40M | $37M | $41M | $42M | · | $32M | $37M | $33M | · | $30M | |
| Current Liabilities | $143M | $135M | $171M | $109M | $112M | $116M | $82M | $72M | $80M | $100M | · | $96M | $97M | $82M | · | $60M | |
| Capital Leases | $10M | $10M | $11M | $10M | $11M | $11M | $12M | $12M | $3M | $4M | · | $4M | $5M | $5M | · | $6M | |
| Total Liabilities | $800M | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M | $711M | · | $572M | $574M | $554M | · | $532M | |
| Long-term Debt | $319M | $319M | $355M | $110M | $36M | $36M | $36M | $228M | $228M | $264M | · | $273M | $274M | $274M | · | $273M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $-3.23B | $-3.21B | $-3.20B | $-3.18B | $-3.19B | $-3.19B | $-3.20B | $-3.21B | $-3.22B | $-3.22B | · | $-3.23B | $-3.23B | $-3.23B | · | $-3.20B | |
| AOCI | $-19.0K | $-4.0K | $115.0K | $137.0K | $1M | $1M | $1M | $588.0K | · | · | · | $443.0K | $443.0K | · | · | $-1M | |
| Stockholders' Equity | $-67M | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M | $-230M | $-246M | $-252M | $-260M | $-255M | $-251M | $-238M | |
| Liabilities + Equity | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Shares Outstanding | 309,911,682 | 308,907,331 | 307,832,587 | 307,027,189 | 306,332,133 | 303,918,969 | 302,959,782 | 275,775,038 | 274,467,247 | 270,801,781 | · | 269,543,539 | 268,235,145 | 264,278,760 | · | 263,156,165 |
Arus Kas 11
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $-427.0K | |
| Stock-based Comp | $10M | $6M | $7M | $4M | $8M | $5M | $6M | $5M | $6M | $4M | $4M | $5M | $6M | $4M | $3M | $4M | |
| Amort. of Intangibles | $4M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-18M | $-5M | $-8M | $24M | $9M | $-6M | $23M | $9M | $4M | $7M | $22M | $9M | $3M | $1M | $-2M | $-28M | |
| CapEx | $5M | $2M | $2M | $1M | $1M | $330.0K | $3M | $1M | $3M | $2M | $6M | $11M | $17M | $8M | $5M | $271.0K | |
| Investing Cash Flow | $18M | $19M | $-292M | $-25M | $6M | $6M | $48M | $-41M | $-55M | $-48M | $-8M | $-12M | $4M | $14M | $15M | $27M | |
| Financing Cash Flow | $559.0K | $-35M | $247M | $72M | $-6M | $1M | $-87M | $-2M | $-45M | $-3M | $142M | $-283.0K | $-6M | $1M | $3M | $20M | |
| Net Change in Cash | $97.0K | $-22M | $-53M | $70M | $10M | $975.0K | $-16M | $-34M | $-96M | $-45M | $155M | $-3M | $315.0K | $16M | $15M | $19M | |
| Taxes Paid | $753.0K | $63.0K | $549.0K | $80.0K | $869.0K | $207.0K | $2M | $236.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-7M | · | · | · | $4M | · | · | · | $-7M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2M | · | · | · | $-10M | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| Net Margin | · | -18.4% | · | 9.7% | 0.87% | 16.8% | · | 16.5% | -2.8% | 16.0% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| Pretax Margin | · | -18.1% | · | 9.5% | 1.2% | 17.4% | · | 18.4% | -2.3% | 16.4% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| EBITDA Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| ROA | · | -2.9% | · | 1.7% | 0.16% | 2.9% | · | 2.9% | -0.53% | 2.7% | · | 0.56% | -1.8% | -3.2% | · | -5.4% | |
| ROE | · | 28.2% | · | -6.3% | -0.48% | -9.1% | · | -5.0% | 0.83% | -4.4% | · | -0.70% | 2.1% | 4.0% | · | 6.8% | |
| ROIC | · | 2.9% | · | -43.5% | -6.8% | -36.8% | · | -5.5% | -8.8% | -7.1% | · | -2.0% | -0.66% | 2.4% | · | · |
Likuiditas & Solvabilitas 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 3.3 | 2.5 | 2.4 | · | 4.5 | 4.1 | 3.8 | · | 2.3 | 2.4 | 2.7 | · | 3.7 | |
| Quick Ratio | · | 1.2 | · | 2.5 | 1.8 | 1.8 | · | 3.7 | 3.4 | 3.2 | · | 1.7 | 1.8 | 2.3 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 2.7 | 6.5 | · | 1.8 | 0.3 | -2.5 | · | · |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.1 | 3.2 | · | 4.6 | 3.0 | 3.2 | · | 3.5 | 2.8 | 3.3 | · | 2.3 | 2.3 | 2.8 | · | 2.0 |
Valuasi (TTM) 9
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $358M | $327M | · | $307M | $297M | $287M | · | $260M | $239M | $207M | · | $173M | $141M | $104M | · | $86M | |
| Net Income TTM | $-27M | $5M | · | $33M | $23M | $33M | · | $22M | $5M | $-3M | · | $-28M | $-59M | $-79M | · | $-74M | |
| Market Cap | $1.32B | $757M | · | $1.65B | $1.15B | $1.53B | · | $1.73B | $1.43B | $1.23B | · | $1.11B | $1.09B | $1.08B | · | $813M | |
| P/E | -53.2 | 122.5 | · | 48.8 | 53.4 | 45.7 | · | 78.6 | 261.0 | -453.0 | · | -37.5 | -17.7 | -13.2 | · | -10.7 | |
| P/S | 3.7 | 2.3 | · | 5.4 | 3.9 | 5.3 | · | 6.7 | 6.0 | 5.9 | · | 6.4 | 7.7 | 10.4 | · | 9.5 | |
| P/B | -19.6 | -12.8 | · | -37.0 | -20.8 | -26.1 | · | -8.3 | -6.3 | -5.3 | · | -4.4 | -4.2 | -4.2 | · | -3.4 | |
| P / Cash Flow | · | -141.1 | · | · | · | -239.7 | · | · | · | 183.0 | · | · | · | 937.3 | · | · | |
| P / FCF | · | -104.5 | · | · | · | -227.9 | · | · | · | 285.6 | · | · | · | -151.4 | · | · | |
| Earnings Yield | -1.9% | 0.82% | · | 2.1% | 1.9% | 2.2% | · | 1.3% | 0.38% | -0.22% | · | -2.7% | -5.7% | -7.6% | · | -9.4% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $349M | $286M | $199M | $100M | $75M |
| Margin Operasi % | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% |
| Laba Bersih | $6M | $28M | $-12M | $-87M | $-81M |
| EPS Dilusian | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 |
| Rasio Cepat | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $14M | $33M | $-8M | $-88M | $-73M |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
- Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
- MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
- H.C. Wainwright dan Wells Fargo Menaikkan Target Harga MannKind (MNKD)
- Apakah MannKind Corporation (MNKD) Salah Satu Saham Penny Populer di Robinhood untuk Dibeli?
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 271 pengaju · $560.6M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 55 (+12 vs Kuartal sebelumnya) | 37 (-11 vs Kuartal sebelumnya) | 93 (+10 vs Kuartal sebelumnya) | 61 (-8 vs Kuartal sebelumnya) | +24.2M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Rubric Capital Management LP | $76.680.000 | 18.000.000 | 13,68% | Saham |
| STATE STREET CORP | $68.901.423 | 16.174.043 | 12,29% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $56.101.610 | 13.169.392 | 10,01% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $29.027.881 | 6.812.460 | 5,18% | Saham |
| Frazier Life Sciences Management, L.P. | $28.116.000 | 6.600.000 | 5,01% | Saham |
| Deep Track Capital, LP | $25.560.000 | 6.000.000 | 4,56% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $23.099.232 | 5.422.355 | 4,12% | Saham |
| 180 WEALTH ADVISORS, LLC | $21.126.835 | 4.959.351 | 3,77% | Saham |
| FMR LLC | $17.455.563 | 4.097.550 | 3,11% | Saham |
| TSP Capital Management Group, LLC | $16.923.596 | 3.972.675 | 3,02% | Saham |
| BRAIDWELL LP | $14.732.908 | 3.458.429 | 2,63% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.789.240 | 3.002.169 | 2,28% | Saham |
| VANGUARD GROUP INC | $11.888.249 | 2.096.693 | 2,12% | Saham |
| TWO SIGMA INVESTMENTS, LP | $11.475.213 | 2.693.712 | 2,05% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.070.577 | 2.598.727 | 1,97% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $9.358.279 | 2.196.779 | 1,67% | Saham |
| BANK OF AMERICA CORP /DE/ | $8.689.749 | 2.039.847 | 1,55% | Saham |
| GOLDMAN SACHS GROUP INC | $6.332.618 | 1.486.530 | 1,13% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.030.221 | 1.180.803 | 0,90% | Saham |
| BlackRock, Inc. | $4.766.748 | 1.118.955 | 0,85% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $4.486.321 | 1.053.127 | 0,80% | Saham |
| Caption Management, LLC | $4.260.000 | 1.000.000 | 0,76% | Opsi jual |
| J. Goldman & Co LP | $3.478.669 | 816.589 | 0,62% | Saham |
| WELLS FARGO & COMPANY/MN | $3.473.987 | 815.490 | 0,62% | Saham |
| SCOPIA CAPITAL MANAGEMENT LP | $2.960.534 | 694.961 | 0,53% | Saham |
| Balyasny Asset Management L.P. | $2.914.296 | 684.107 | 0,52% | Saham |
| TWO SIGMA ADVISERS, LP | $2.897.166 | 510.964 | 0,52% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $2.771.407 | 650.565 | 0,49% | Saham |
| Swiss National Bank | $2.502.324 | 587.400 | 0,45% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $2.177.052 | 511.045 | 0,39% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.106.540 | 494.493 | 0,38% | Saham |
| 1492 Capital Management LLC | $2.052.136 | 481.722 | 0,37% | Saham |
| Mariner, LLC | $2.020.189 | 474.236 | 0,36% | Saham |
| MILLENNIUM MANAGEMENT LLC | $1.836.597 | 431.126 | 0,33% | Saham |
| Schonfeld Strategic Advisors LLC | $1.774.216 | 416.483 | 0,32% | Saham |
| Squarepoint Ops LLC | $1.759.644 | 413.062 | 0,31% | Saham |
| Jefferies Financial Group Inc. | $1.694.202 | 397.700 | 0,30% | Saham |
| ExodusPoint Capital Management, LP | $1.666.261 | 391.141 | 0,30% | Saham |
| JANE STREET GROUP, LLC | $1.658.418 | 389.300 | 0,30% | Opsi beli |
| Man Group plc | $1.624.023 | 381.226 | 0,29% | Saham |
| RHUMBLINE ADVISERS | $1.604.647 | 376.681 | 0,29% | Saham |
| IEQ CAPITAL, LLC | $1.544.607 | 362.584 | 0,28% | Saham |
| CITIGROUP INC | $1.499.243 | 351.935 | 0,27% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.423.692 | 334.200 | 0,25% | Opsi jual |
| Bank of New York Mellon Corp | $1.422.222 | 333.855 | 0,25% | Saham |
| Caption Management, LLC | $1.414.231 | 331.979 | 0,25% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.359.221 | 319.066 | 0,24% | Saham |
| ALPS ADVISORS INC | $1.330.615 | 312.351 | 0,24% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.216.230 | 285.500 | 0,22% | Opsi beli |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.029.075 | 241.567 | 0,18% | Saham |
| BARCLAYS PLC | $1.029.062 | 241.564 | 0,18% | Saham |
| Rafferty Asset Management, LLC | $1.008.640 | 236.770 | 0,18% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $1.002.715 | 235.379 | 0,18% | Saham |
| Aaron Wealth Advisors LLC | $1.000.878 | 234.948 | 0,18% | Saham |
| HSBC HOLDINGS PLC | $998.560 | 230.881 | 0,18% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $930.294 | 379.712 | 0,17% | Saham |
| CITADEL ADVISORS LLC | $928.680 | 218.000 | 0,17% | Opsi beli |
| CITADEL ADVISORS LLC | $898.860 | 211.000 | 0,16% | Opsi jual |
| Bruce & Co., Inc. | $831.011 | 195.073 | 0,15% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $775.060 | 181.939 | 0,14% | Saham |
| MetLife Investment Management, LLC | $766.442 | 179.916 | 0,14% | Saham |
| FRANKLIN RESOURCES INC | $755.021 | 177.235 | 0,13% | Saham |
| Stonepine Capital Management, LLC | $750.000 | 250.000 | 0,13% | Opsi beli |
| UBS Group AG | $715.978 | 168.070 | 0,13% | Saham |
| ALLIANCEBERNSTEIN L.P. | $693.375 | 283.010 | 0,12% | Saham |
| MORGAN STANLEY | $651.282 | 152.883 | 0,12% | Saham |
| TUDOR INVESTMENT CORP ET AL | $640.657 | 150.389 | 0,11% | Saham |
| RAYMOND JAMES FINANCIAL INC | $632.009 | 148.359 | 0,11% | Saham |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $613.437 | 171.372 | 0,11% | Saham |
| Jain Global LLC | $604.673 | 141.942 | 0,11% | Saham |
| KING LUTHER CAPITAL MANAGEMENT CORP | $590.457 | 138.605 | 0,11% | Saham |
| Susquehanna Portfolio Strategies, LLC | $574.538 | 134.868 | 0,10% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $570.354 | 133.886 | 0,10% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $557.723 | 130.921 | 0,10% | Saham |
| PROFUND ADVISORS LLC | $517.726 | 121.532 | 0,09% | Saham |
| Invesco Ltd. | $512.389 | 120.279 | 0,09% | Saham |
| Vanguard Global Advisers, LLC | $509.833 | 119.679 | 0,09% | Saham |
| KLP KAPITALFORVALTNING AS | $491.604 | 115.400 | 0,09% | Saham |
| Gotham Asset Management, LLC | $452.463 | 106.212 | 0,08% | Saham |
| State of New Jersey Common Pension Fund D | $403.171 | 94.641 | 0,07% | Saham |
| State of Wyoming | $403.149 | 94.636 | 0,07% | Saham |
| Police & Firemen's Retirement System of New Jersey | $386.834 | 90.806 | 0,07% | Saham |
| Amundi | $374.310 | 87.866 | 0,07% | Saham |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $373.478 | 87.671 | 0,07% | Saham |
| NEW YORK STATE COMMON RETIREMENT FUND | $359.966 | 84.499 | 0,06% | Saham |
| ARIZONA STATE RETIREMENT SYSTEM | $344.050 | 80.763 | 0,06% | Saham |
| Mitsubishi UFJ Asset Management Co., Ltd. | $338.155 | 79.379 | 0,06% | Saham |
| Aquatic Capital Management LLC | $335.300 | 78.709 | 0,06% | Saham |
| Rockefeller Capital Management L.P. | $332.996 | 78.168 | 0,06% | Saham |
| Vanguard Investments Australia, Ltd. | $314.929 | 73.927 | 0,06% | Saham |
| JANUS HENDERSON GROUP PLC | $313.658 | 127.763 | 0,06% | Saham |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $312.203 | 73.287 | 0,06% | Saham |
| Sequoia Financial Advisors, LLC | $296.935 | 69.703 | 0,05% | Saham |
| INTECH INVESTMENT MANAGEMENT LLC | $284.653 | 66.820 | 0,05% | Saham |
| COMMONWEALTH EQUITY SERVICES, LLC | $280.421 | 65.827 | 0,05% | Saham |
| China Universal Asset Management Co., Ltd. | $262.714 | 61.670 | 0,05% | Saham |
| LPL Financial LLC | $260.060 | 61.047 | 0,05% | Saham |
| SIMPLEX TRADING, LLC | $258.790 | 60.749 | 0,05% | Saham |
| Cetera Investment Advisers | $241.546 | 56.701 | 0,04% | Saham |
| Painted Porch Advisors LLC | $227.620 | 53.432 | 0,04% | Saham |
Orang dalam perusahaan 43 orang dalam · 27 pejabat · 18 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Michael Castagna | Chief Executive Officer | 15 Juli 2026 M | 2.433.779 | 1 | 4 | $-990.292 |
| Hakan Edstrom | President & CEO | 27 Agu 2015 A | 1.114.340 | 0 | 0 | $0 |
| Christopher B Prentiss | Chief Financial Officer | 15 Juli 2026 F | 318.668 | 0 | 0 | $0 |
| Juergen Martens | Corporate VP and COO | 27 Agu 2015 A | 106.539 | 0 | 0 | $0 |
| Dominic Marasco | Pres, Endocrine Business Unit | 15 Juli 2026 F | 343.398 | 0 | 0 | $0 |
| Sanjay R Singh | EVP Technical Operations | 15 Juli 2026 M | 478.966 | 0 | 1 | $-94.448 |
| Stuart A Tross | Chief People & Workpl Officer | 15 Juli 2026 M | 1.058.142 | 0 | 2 | $-548.528 |
| David Thomson | EVP Genl Counsel & Secretary | 15 Juli 2026 M | 797.554 | 0 | 3 | $-930.755 |
| Ajay Ahuja | Chief Medical Officer | 23 Maret 2026 A | 318.200 | 0 | 0 | $0 |
| Lauren M Sabella | EVP Operations | 15 Juli 2025 F | 349.841 | 0 | 0 | $0 |
| Burkhard Blank | EVP Chief Medical Officer | 15 Juli 2025 F | 460.791 | 0 | 0 | $0 |
| Joseph Kocinsky | Chief Technology Officer | 27 Agu 2022 F | 745.233 | 0 | 0 | $0 |
| Alejandro Galindo | EVP Endocrine Business Unit | 28 Feb. 2022 A | 576.690 | 0 | 0 | $0 |
| Rosabel Realica Alinaya | VP, IR & Treasury | 27 Agu 2020 A | 167.119 | 0 | 0 | $0 |
| David M Kendall | Chief Medical Officer | 31 Juli 2020 P | 41.059 | 0 | 0 | $0 |
| Patrick Mccauley | Chief Commercial Officer | 25 Feb. 2020 A | 83.972 | 0 | 0 | $0 |
| Courtney Barton | Chief Compl & Privacy Officer | 31 Juli 2019 P | 29.584 | 0 | 0 | $0 |
| Elizabeth Garrett Ingram | Chief Marketing Officer | 14 Mei 2019 A | 43.012 | 0 | 0 | $0 |
| Raymond W. Urbanski | Corp VP, CMO | 10 Agu 2017 S | 2.924 | 0 | 0 | $0 |
| Linda A Adreveno | Sr. VP, HR | 18 Feb. 2016 A | 92.200 | 0 | 0 | $0 |
| Alfred E Mann | Executive Chairman | 22 Agu 2015 F | 1.005.990 | 0 | 0 | $0 |
| Diane Palumbo | Vice President, Human Resource | 23 Feb. 2015 F | 50.624 | 0 | 0 | $0 |
| Peter C Richardson | Chief Scientific Officer | 3 Maret 2012 F | 133.611 | 0 | 0 | $0 |
| Richard L Anderson | Corporate VP | 16 Nov. 2008 F | 204.401 | 0 | 0 | $0 |
| John R. Riesenberger | VP & Chief Commercial Officer | 13 Agu 2008 A | 14.650 | 0 | 0 | $0 |
| Dan Burns | VP & President, MKBP | 8 Des. 2006 A | 14.800 | 0 | 0 | $0 |
| Wendell W Cheatham | VP, Medical & Reg Affairs | 19 Agu 2004 A | 300 | 0 | 0 | $0 |
| Sabrina Kay | Direktur | 20 Mei 2026 A | 265.600 | 0 | 0 | $0 |
| Jennifer Grancio | Direktur | 20 Mei 2026 A | 244.815 | 0 | 0 | $0 |
| James Samuel Shannon | Direktur | 20 Mei 2026 A | 64.635 | 0 | 0 | $0 |
| Michael A Friedman | Direktur | 20 Mei 2026 A | 47.500 | 0 | 0 | $0 |
| Anthony C Hooper | Direktur | 20 Mei 2026 A | 236.153 | 0 | 0 | $0 |
| Christine Mundkur | Direktur | 20 Mei 2026 A | 254.493 | 0 | 0 | $0 |
| Ronald J Consiglio | Direktur | 20 Mei 2026 A | 132.342 | 0 | 0 | $0 |
| Kent Kresa | Direktur | 15 Mei 2024 A | 274.541 | 0 | 0 | $0 |
| Henry L Nordhoff | Direktur | 14 Mei 2019 A | 103.426 | 0 | 0 | $0 |
| David Maccallum | Direktur | 16 Mei 2018 A | 114.790 | 0 | 0 | $0 |
| Matthew J Pfeffer | Direktur | 28 Agu 2017 F | 81.961 | 0 | 0 | $0 |
| Abraham E Cohen | Direktur | 17 Agu 2012 S | 56.424 | 0 | 0 | $0 |
| Heather Hay Murren | Direktur | 13 Agu 2008 A | 10.100 | 0 | 0 | $0 |
| Kathleen Connell | Direktur | 25 Mei 2006 A | — | 0 | 0 | $0 |
| Llew Keltner | Direktur | 25 Mei 2006 A | — | 0 | 0 | $0 |
| Steven B. Binder | — | 7 Agu 2026 S | 785.867 | 0 | 3 | $-427.369 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 pengajuan | 10 Juli 2012 | — | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 31 Jan. 2006 | — | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 41 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| RNIN · EA Series Trust | 1,43% | 773.251 NS | 30 April 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,74% | 317.578 NS | 31 Mei 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 29.662 SH | 8 Agu 2026 | Harian |
| AGNG · Global X Funds | 0,46% | 98.947 NS | 31 Mei 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,34% | 625.921 NS | 30 April 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,11% | 64.525 NS | 31 Mei 2026 | N-PORT |
| IBB · iShares Trust | 0,09% | 2.170.137 SH | 8 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,09% | 16.814 SH | 8 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 330.117 SH | 8 Agu 2026 | Harian |
| IWO · iShares Trust | 0,07% | 2.772.931 SH | 8 Agu 2026 | Harian |
| ESML · iShares Trust | 0,06% | 449.515 SH | 8 Agu 2026 | Harian |
| BIB · ProShares Trust | 0,06% | 11.389 NS | 31 Mei 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 114.273 NS | 30 April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1.771.496 SH | 8 Agu 2026 | Harian |
| IWM · iShares Trust | 0,04% | 7.830.029 SH | 8 Agu 2026 | Harian |
| ISCG · iShares Trust | 0,04% | 94.032 SH | 8 Agu 2026 | Harian |
| ITWO · ProShares Trust | 0,03% | 14.400 NS | 31 Mei 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 132.607 NS | 30 April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 1.466.402 NS | 31 Mei 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 61.465 NS | 31 Mei 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 874.372 SH | 8 Agu 2026 | Harian |
| ISCB · iShares Trust | 0,02% | 13.557 SH | 8 Agu 2026 | Harian |
| UWM · ProShares Trust | 0,02% | 11.261 NS | 31 Mei 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 135.688 NS | 30 April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 638.128 NS | 30 April 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 11.390 NS | 31 Mei 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 3.543.398 SH | 8 Agu 2026 | Harian |
| WSML · iShares Trust | 0,01% | 16.464 SH | 8 Agu 2026 | Harian |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 12.000 NS | 31 Mei 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 286 NS | 31 Mei 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 452.118 NS | 30 April 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 27.701 NS | 30 April 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 1.330 NS | 31 Mei 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 465.445 SH | 8 Agu 2026 | Harian |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 196.006 NS | 31 Mei 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 83.220 SH | 8 Agu 2026 | Harian |
| TILT · FlexShares Trust | 0,00% | 10.345 NS | 30 April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 32.093 NS | 30 April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 14.557 NS | 30 April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9.327.332 SH | 8 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26.184 SH | 8 Agu 2026 | Harian |